Interview with Professor Juan Miguel Bayo Fina from the Faculty of Biomedical Sciences of the Universidad Austral A research fellow at CONICET and the Institute of Translational Medicine Research, he appeared on the program "El Interactivo" on Ciudadano News in Mendoza province to discuss a new experimental therapeutic strategy that could benefit patients with severe liver disease. In a significant advance for Argentine translational science, researchers from the Laboratory of Experimental Hepatology and Gene Therapy (IIMT) have identified, for the first time, an effective therapeutic pathway to treat fulminant hepatitis, a condition that can cause death in up to 40% of cases without transplantation.